102 related articles for article (PubMed ID: 170046)
1. [First clinical trials of treatment of primary liver cancer with immunostimulating agents administered by systemic or intratumoral route].
Tung TT; Bang NH; Van Ton NV; Bach T; Tam ND; Salomon JC
Chirurgie; 1975 Jun 11-25; 101(8):542-5. PubMed ID: 170046
[No Abstract] [Full Text] [Related]
2. Assessment of the palliative treatment in primary liver cancer.
Chearanai O; Boonyapisit S; Plengvanit U
J Med Assoc Thai; 1979 Sep; 62(9):487-93. PubMed ID: 92514
[No Abstract] [Full Text] [Related]
3. [Immunotherapy of lung cancer].
Jassem J; Jassem E
Pol Tyg Lek; 1982 Jun; 37(17):497-9. PubMed ID: 6292882
[No Abstract] [Full Text] [Related]
4. Primary liver cancer in Thailand.
Viranuvatti V
Trop Gastroenterol; 1984; 5(2):75-82. PubMed ID: 6100806
[No Abstract] [Full Text] [Related]
5. Treatment of neoplasms of the liver.
Spellberg MA
Am J Gastroenterol; 1969 Oct; 52(4):326-33. PubMed ID: 4309902
[No Abstract] [Full Text] [Related]
6. [Primary liver cancer. Personal experience in diagnosis and therapy].
Weber P; Martínek K; Weberová D
Cas Lek Cesk; 1988 Mar; 127(10):298-301. PubMed ID: 2835161
[No Abstract] [Full Text] [Related]
7. Effect of immunostimulating agents on viral infections.
Zerial A; Werner GH
Acta Microbiol Acad Sci Hung; 1981; 28(3):325-37. PubMed ID: 6171144
[No Abstract] [Full Text] [Related]
8. Temporary occlusion of the hepatic artery plus infusion and systemic chemotherapy for inoperable cancer of the liver.
Lise M; Cagol PP; Nitti D; Feltrin G; Fosser V; Cecchetto A; Rubaltelli L; Pucciarelli S
Int Surg; 1980; 65(4):315-23. PubMed ID: 6164663
[TBL] [Abstract][Full Text] [Related]
9. Primary carcinoma of the liver.
McBride CM
Surgery; 1976 Sep; 80(3):322-7. PubMed ID: 183298
[TBL] [Abstract][Full Text] [Related]
10. Experience gained in immunotherapy from the immunopharmacology of BCG leading to a second generation of systemic immunity adjuvants.
Mathe G
Comp Immunol Microbiol Infect Dis; 1980; 3(4):407-32. PubMed ID: 6451350
[No Abstract] [Full Text] [Related]
11. Immunotherapy of guinea pig cancer with BCG.
Zbar B
Johns Hopkins Med J Suppl; 1974; 3():121-30. PubMed ID: 4608693
[No Abstract] [Full Text] [Related]
12. Comparative aspects of cancer immunotherapy: immunologic methods used for treatment of spontaneous cancer in animals.
Theilen GH; Hills D
J Am Vet Med Assoc; 1982 Nov; 181(10):1134-41. PubMed ID: 6757216
[No Abstract] [Full Text] [Related]
13. Immune adjuvant therapy in lung cancer.
Holmes EC
Prog Exp Tumor Res; 1980; 25():229-41. PubMed ID: 6986634
[No Abstract] [Full Text] [Related]
14. Evaluation of intratumoral immunostimulants in the treatment of a transplantable rat mammary carcinoma.
Willmott N; Austin EB; Pimm MV; Baldwin RW
Eur J Cancer (1965); 1981 Apr; 17(4):397-405. PubMed ID: 7308253
[No Abstract] [Full Text] [Related]
15. Current concepts in the management of primary liver-cell carcinoma.
Balasegaram M
Clin Oncol; 1975 Jun; 1(2):111-20. PubMed ID: 171114
[No Abstract] [Full Text] [Related]
16. Immune modulating therapy in gastrointestinal cancer.
Chachoua A; Green M; Muggia FM
Am J Gastroenterol; 1986 Aug; 81(8):623-8. PubMed ID: 2426941
[No Abstract] [Full Text] [Related]
17. [Bone metastasis of primary of the liver carcinoma. (Apropos of 5 anatomoclinical cases)].
Cayla J; Rondier J; Heisbourg A; de Saint-Maur P; Delbarre F
Rev Rhum Mal Osteoartic; 1971; 38(8):515-31. PubMed ID: 4333991
[No Abstract] [Full Text] [Related]
18. [Intraarterial and intraportal chemotherapy combined with decollateralization for cholangiocellular carcinoma and metastatic liver cancer].
Nagano H; Sasaki Y; Imaoka S; Masutani S; Ohashi I; Ishikawa O; Oohigashi H; Yasuda T; Furukawa H; Fukuda I
Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1758-62. PubMed ID: 2167649
[TBL] [Abstract][Full Text] [Related]
19. [Long-term results of chemoembolization of primary liver cancer with epirubicin-lipiodol].
Pirschel J; Lauchart W
Helv Chir Acta; 1993 Mar; 59(4):631-6. PubMed ID: 8386147
[TBL] [Abstract][Full Text] [Related]
20. Combination chemotherapy plus methanol extracted residue of bacillus Calmette-Guérin or Corynebacterium parvum in stage III lung cancer.
Bjornsson S; Takita H; Kuberka N; Preisler H; Catane H; Higby D; Henderson E
Cancer Treat Rep; 1978 Apr; 62(4):505-10. PubMed ID: 350388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
